Outsourcing

Meg Rivers is the former senior editor for 

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Videos

Pharmaceutical Technology editors interview aseptic and sterilization experts from Watson-Marlow Fluid Technology Solutions and Cherwell—diving into sterilization, aseptic processing, and the revised EU GMP Annex 1 guidance.

Drug Digest: Sterilization’s Horizon: Improving Automation, Single-Use Technologies, and Annex 1

Articles

The latest CPHI report has been published, predicting that a significant shift in outsourcing strategies is being experienced globally.

CPHI Report Predicts Significant Shifts in Global Outsourcing Strategies

Podcasts

In this episode of the Drug Solutions Podcast, John Koleng, VP of product development and manufacturing for TFF Pharmaceuticals shares outsourcing strategies in biopharma.

Drug Solutions Podcast: Outsourcing vs. Insourcing in Biopharma: Determining the Best Strategy: Part 1

Following the acquisition by Altaris Capital Partners, Johnson Matthey Health has rebranded as Veranova.

Johnson Matthey Health Rebrands as Veranova

In this episode of the Drug Solutions Podcast, Meg Rivers, senior editor, discusses the importance of proper training for aseptic processing with Patrick Nieuwenhuizen, director senior consultant, PharmaLex.

Drug Solutions Podcast: The Criticality of Training in Aseptic Processing

Industry experts discuss the need for stricter environmental controls, whether to incorporate single-use technologies, and areas for improved automation.  

Automating Aseptic Processing Reduces Contamination Risk

The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.

Connecting the Dots for Pharma

Susan J. Schniepp is a fellow at Regulatory Compliance Associates, Inc. and a member of Pharmaceutical Technology's Editorial Advisory Board.

Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the basics for maintaining an acceptable working relationship between a client and their CDMO.

Productive Client-CDMO Relationships

Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.

Lonza, IBF Collaborate to Support Development and Manufacturing of Biologics and Small Molecules

Scott Whyte is the chief digital officer for AeroSafe Global.

With the majority of large pharmaceutical manufacturers aiming for carbon neutrality by 2030, reusable packaging remains a largely untapped approach in achieving measurable ESG gains.

Contract Manufacturing Services